Ashwagandha Dosage, Timing and Cycling

Examples of studied regimens

In a randomized placebo-controlled pilot trial of 50 adults with mild cognitive impairment, ashwagandha root extract was studied at 300 mg twice daily for eight weeks. This is the regimen from one selected trial, not evidence of the most common, recommended, maximum, or universally effective dose. It should not be transferred to another product or used as individualized dosing advice.^[1]

In randomized placebo-controlled trials and meta-analyses, ashwagandha supplementation has been studied for, and associated with, reductions in perceived stress and serum cortisol in adults with elevated stress. Doses studied were about 300 mg twice daily and 240 mg per day over roughly 60 days; pooled certainty has been rated low, individual responses vary, and these findings are not a substitute for individual medical advice.^{[2], [4], [5], [6]}

Once-daily and split-dose examples

The 2019 stress trial described Shoden as a standardized ashwagandha root extract, prepared using ethanol and water and containing 35% withanolide glycosides; 60 adults with mild stress took 240 mg once daily after dinner for 60 days. This describes the formulation in that paper, whose root-extract wording should not be assumed to identify the plant parts of every current Shoden product. Its milligrams and withanolide-glycoside percentage do not establish equivalence or superiority to differently standardized extracts.^[2]

The 2025 postmenopause trial studied Sensoril aqueous ashwagandha extract from roots and aerial parts at 250 or 500 mg/day, divided morning and evening after meals for 24 weeks. The selected postmenopausal population and small groups do not establish a dose for other goals, equivalence to other preparations or safety over many months or years.^[3]

Timing, meals, cycling and stopping

The selected Shoden stress trial and Sensoril postmenopause trial used daily scheduled supplementation, with an after-dinner dose or morning/evening doses after meals; neither randomized participants to alternative dosing times, cycling, tapering or stopping schedules. These protocols do not identify the best time of day, prove food improves absorption, establish a cycling schedule, or determine how effects persist after discontinuation. Their 60-day and 24-week observation periods are not evidence of safety or efficacy over years.^{[2], [3]}

Reported safety data for ashwagandha come mostly from short trials in selected populations, and meta-analyses note that information on long-term safety remains limited.^{[4], [7]}

Safety and medication context

NCCIH does not recommend ashwagandha for people with thyroid or autoimmune disorders or those who are about to have surgery. Discuss these conditions and any planned surgery with your healthcare professional before considering ashwagandha; supplement research does not justify changing prescribed care.^[8]

Ashwagandha may interact with medicines for diabetes or high blood pressure, immunosuppressants, sedatives, anticonvulsants, and thyroid hormone medicines. Discuss possible interactions with your prescriber or pharmacist before use; do not stop, replace, or adjust prescribed medicines based on supplement information.^[8]

Read the concise FAQ answer

Use the FAQ when you want the direct answer first, then return here for the full evidence context.